Does Medicaid Cover Vivitrol
Yes, every state Medicaid program covers Vivitrol. The differences across states are not "is it covered" but "how hard is it to get authorized." Some states wave Vivitrol through as preferred. Others require prior authorization paperwork that can delay the first shot by 24 to 72 hours. The state-by-state table below comes from the most recent KFF Medicaid Behavioral Health Services survey.
The billing basics
Vivitrol is billed under HCPCS code J2315 (injection, naltrexone, depot form, 1mg). The standard 380mg dose is billed as 380 units of J2315. Most state Medicaid programs reimburse at AWP minus a percentage, plus an administration fee (typically billed as CPT 96372 for therapeutic injection). The clinic gets reimbursed within 30 to 90 days of submitting the claim.
For the patient, the experience is simpler. Most state Medicaid programs charge zero copay for Vivitrol or a small copay (usually $1 to $5). The patient does not see the J2315 code or the AWP. They see "covered" or "not covered" based on their state and plan.
Prior authorization patterns
Prior authorization is the most common friction point. States that require prior auth typically want documentation of:
- Confirmed diagnosis of opioid use disorder or alcohol use disorder (DSM-5 criteria)
- Failed trial of oral naltrexone or other AUD medication, in some states
- Confirmation that the patient is opioid-free (for OUD use)
- Counseling or behavioral intervention plan
States with no prior auth or "preferred drug" status for Vivitrol generally allow same-day initiation. States with prior auth typically take 24 to 72 hours to approve. Some states have step therapy requirements that can add days.
State-by-state Medicaid Vivitrol coverage
| State | Naltrexone covered | Prior auth required | Notes |
|---|---|---|---|
| California | Yes | Y | CA Drug Medi-Cal Organized Delivery System (DMC-ODS) uses ASAM criteria for placement; PA requirements vary by county; MCO criteria apply for ER formulations |
| Florida | Yes | Y | FL Medicaid managed care (SMMC MMA plans) may impose plan-specific PA; no universal state PA policy published for fee-for-service |
| Massachusetts | Yes | Y | PA required for providers outside BESMART-equivalent MAT networks; MA Medicaid requires PA for some residential levels via MCO/ACO/PIHP |
| New York | Yes | Limited | NY covers all behavioral health services including 100% of SUD services queried in 2022 KFF survey; NY operates specialized managed care plan for adults needing supportive BH services; PA requirements generally limited per NY's comprehensive coverage model |
| Ohio | Yes | Y | OH implemented standardized behavioral health treatment prior authorization form in July 2021; MCPs required to cover next available LOC if recommended LOC unavailable geographically |
| Pennsylvania | Yes | Y | PA SUD 1115 waiver adopted ASAM placement criteria; PA MCOs cover OUD treatment per waiver terms; PA revised prior authorization guidelines for opioid prescriptions |
| Tennessee | Yes | Limited | TN TennCare: outpatient drug coverage for all enrollees via single PBM; BESMART network has reduced PA requirements for participating buprenorphine prescribers; providers outside BESMART network may face PA; TN has no FFS enrollees (all managed care) |
| Texas | Yes | Y | TX Medicaid is heavily managed care-based; PA requirements imposed by MCOs vary by plan; contingency management waiver amendment submitted but not confirmed approved as of 2024 |
Source: KFF Medicaid Behavioral Health Services Survey. Naltrexone coverage applies to both oral and Vivitrol forms in most states.
What to do if your prior auth is denied
Denials happen for three common reasons. The prescriber did not submit complete documentation. The state requires step therapy and the patient has not failed oral naltrexone first. The patient does not meet the state's specific criteria for "treatment-resistant" classification.
The fastest fix: have the prescriber call the state Medicaid pharmacy benefits manager directly. Most denials get reversed during a brief peer-to-peer review when the prescriber explains the clinical situation. Written appeals take longer (sometimes weeks) but also have high reversal rates.
Medicaid managed care vs fee-for-service
Most Medicaid beneficiaries are now enrolled in managed care plans (MCOs) rather than traditional fee-for-service Medicaid. The state Medicaid agency sets minimum coverage requirements, but each MCO can have its own preferred drug list, prior auth rules, and step therapy requirements. Two beneficiaries in the same state might face different Vivitrol authorization processes depending on which MCO they have.
Practical implication: the prescriber needs to know which MCO the patient has, not just which state. The MCO's pharmacy benefit manager (often Express Scripts, CVS Caremark, or OptumRx) is who issues the actual approval.